Alzamend Neuro, Inc.
ALZN · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,449 | $5,621 | $3,949 | $3,358 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $272 | $308 | $229 | $589 |
| Total Curr. Assets | $4,721 | $5,929 | $4,177 | $3,947 |
| Property Plant & Equip (Net) | $370 | $398 | $426 | $228 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $370 | $398 | $426 | $228 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,092 | $6,327 | $4,603 | $4,176 |
| Liabilities | – | – | – | – |
| Payables | $0 | $983 | $635 | $726 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $717 | $0 | $0 | $0 |
| Total Curr. Liab. | $717 | $983 | $635 | $726 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $717 | $983 | $635 | $726 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $1 |
| Retained Earnings | -$62,239 | -$61,238 | -$58,535 | -$57,396 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $66,613 | $66,581 | $62,503 | $60,845 |
| Total Equity | $4,374 | $5,343 | $3,968 | $3,450 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5,092 | $6,327 | $4,603 | $4,176 |
| Net Debt | -$4,449 | -$5,621 | -$3,949 | -$3,358 |